KESIMPTA (ofatumumab)

• KESIMPTA (ofatumumab)

• Topics

• (Abst.) Ofatumumab and enteroviral encephalitis: A severe infectious complication...

  Started by agate on 13 May, 2026 15:10

  Views: 103, Replies: 0

• (Abst.) Real-world safety and effectiveness of ofatumumab in MS:...

  Started by agate on 06 Mar, 2026 19:18

  Views: 142, Replies: 0

• T lymphopenia in MS patients treated with ofatumumab

  Started by agate on 04 Jan, 2026 21:17

  Views: 114, Replies: 0

• (Abst.) 6-year safety and efficacy outcomes w/first-line ofatumumab in recently diagnosed pts. w/relapsing MS

  Started by agate on 12 Dec, 2025 21:13

  Views: 130, Replies: 0

• (Abst.) Association of body mass index and clinical response in MS patients receiving ofatumumab

  Started by agate on 07 Mar, 2025 07:00

  Views: 230, Replies: 0

• (Abst.) Ofatumumab-associated colitis: A case report

  Started by agate on 02 Feb, 2025 07:24

  Views: 170, Replies: 0

• (Abst.) IV ofatumumab treatment of MS and related disorders...

  Started by agate on 25 Oct, 2022 21:20

  Views: 302, Replies: 0

• (Abst.) Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive MS patients

  Started by agate on 25 Jul, 2022 21:25

  Views: 265, Replies: 0

• Ofatumumab

  Started by agate on 25 Jan, 2014 19:47
  Last post by agate on 21 Aug, 2020 07:48

  Views: 1253, Replies: 8